Xiaomei Yang

4.9k total citations
111 papers, 3.6k citations indexed

About

Xiaomei Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaomei Yang has authored 111 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 30 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Xiaomei Yang's work include Ubiquitin and proteasome pathways (11 papers), RNA modifications and cancer (10 papers) and MicroRNA in disease regulation (10 papers). Xiaomei Yang is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), RNA modifications and cancer (10 papers) and MicroRNA in disease regulation (10 papers). Xiaomei Yang collaborates with scholars based in China, United States and United Kingdom. Xiaomei Yang's co-authors include Zhigang Zhang, Ling Zang, Zengxing Zhang, Yahui Wang, Helin Huang, Jun Li, Yanli Zhang, Mingxuan Feng, Shu‐Heng Jiang and Yanke Che and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Gastroenterology.

In The Last Decade

Xiaomei Yang

109 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomei Yang China 37 2.0k 969 583 384 376 111 3.6k
Hua Chen China 30 1.7k 0.9× 854 0.9× 876 1.5× 285 0.7× 272 0.7× 90 3.6k
Tsung‐Ching Lai Taiwan 26 2.1k 1.0× 1.4k 1.4× 471 0.8× 385 1.0× 307 0.8× 57 3.5k
Qiwei Yang China 28 1.9k 1.0× 1.0k 1.1× 544 0.9× 363 0.9× 255 0.7× 111 3.3k
Jiandong Wang China 29 1.3k 0.7× 670 0.7× 553 0.9× 471 1.2× 424 1.1× 139 3.3k
Tokuhiro Chano Japan 31 1.4k 0.7× 542 0.6× 498 0.9× 203 0.5× 403 1.1× 108 2.7k
Xi Zhao China 33 1.4k 0.7× 681 0.7× 657 1.1× 407 1.1× 252 0.7× 91 3.7k
Meng Zhao China 33 1.9k 1.0× 723 0.7× 614 1.1× 486 1.3× 471 1.3× 115 4.7k
Zhenyu Yin China 32 1.8k 0.9× 635 0.7× 515 0.9× 170 0.4× 256 0.7× 87 3.2k
Shinae Kizaka‐Kondoh Japan 35 2.3k 1.1× 1.3k 1.3× 784 1.3× 324 0.8× 338 0.9× 110 4.4k
Yi Du China 28 1.8k 0.9× 660 0.7× 1.4k 2.3× 344 0.9× 429 1.1× 67 3.7k

Countries citing papers authored by Xiaomei Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaomei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Yang more than expected).

Fields of papers citing papers by Xiaomei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Yang. The network helps show where Xiaomei Yang may publish in the future.

Co-authorship network of co-authors of Xiaomei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomei Yang. A scholar is included among the top collaborators of Xiaomei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomei Yang. Xiaomei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shuai, et al.. (2025). Chemosensors for H2O2 Detection: Principles, Active Materials, and Applications. Chemosensors. 13(2). 54–54. 5 indexed citations
2.
3.
Zhou, Ying, Xiaomei Yang, Shulin Zhang, et al.. (2025). Resveratrol inhibits autophagy in cardiomyocytes subjected anoxia/reoxygenation injury: involved in VDAC1/PINK1/Parkin pathway. Toxicology and Applied Pharmacology. 502. 117421–117421. 1 indexed citations
4.
Li, Hongji, Xiaotong Sun, Zhitong Zhao, et al.. (2024). Photothermal catalytic transfer hydrogenolysis of protolignin. Nature Communications. 15(1). 10176–10176. 16 indexed citations
5.
7.
Zhang, Yifan, Qing Li, Pei-Qi Huang, et al.. (2022). A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma. Oncogene. 41(8). 1203–1215. 16 indexed citations
8.
Xu, Huanhuan, Jin Li, Li Jiang, et al.. (2022). Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways. Biomedicine & Pharmacotherapy. 149. 112902–112902. 14 indexed citations
9.
Zhang, Xueli, Li-Peng Hu, Qin Yang, et al.. (2021). CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-β receptors in colorectal cancer. Oncogene. 40(23). 3959–3973. 61 indexed citations
10.
Xu, Hui, et al.. (2021). STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway. Neoplasia. 23(6). 607–623. 19 indexed citations
11.
Zhang, Zhigang, et al.. (2020). STK3 Suppresses Ovarian Cancer Progression by Activating NF‐ κ B Signaling to Recruit CD8 + T‐Cells. Journal of Immunology Research. 2020(1). 7263602–7263602. 11 indexed citations
12.
Lu, Huan, Guangdong Yang, Linyan Zhu, et al.. (2018). Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma. EBioMedicine. 40. 276–289. 67 indexed citations
13.
Zhang, Yanli, Xin Xing, Lei Zhu, et al.. (2018). Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling. Journal of Immunology Research. 2018. 1–11. 27 indexed citations
14.
Yang, Xiaomei, Xiaoyan Cao, Ping He, et al.. (2018). Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Gastroenterology. 155(4). 1233–1249.e22. 90 indexed citations
15.
Feng, Yun, Xirui Chen, Ye Zhang, et al.. (2018). NASP antagonize chromatin accessibility through maintaining histone H3K9me1 in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(10). 3438–3448. 17 indexed citations
16.
Yang, Qin, Chunchao Zhu, Yanli Zhang, et al.. (2018). Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer. Journal of Cancer. 9(16). 2973–2980. 10 indexed citations
17.
Wang, Yahui, Rongkun Li, Ying Fu, et al.. (2017). Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10. Journal of Immunology Research. 2017. 1–9. 6 indexed citations
18.
Sanders, Andrew J., et al.. (2017). Expression of Osteoprotegrin Is Enhanced in Lung Cancer Tissues and Promotes Aggressive Cellular Traits in H3122 Lung Cancer Cells. Anticancer Research. 37(8). 4277–4283. 5 indexed citations
19.
Yang, Xiaomei, Guifang Du, Si Yang, et al.. (2017). A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression. Anticancer Research. 37(1). 67–74. 11 indexed citations
20.
Sheng, Lulu, et al.. (2015). miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2. Cell Death and Disease. 6(7). e1808–e1808. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026